Squamous Cell Carcinoma of Unknown Primary
4 clinical trials · Condition
◉ Watch Squamous Cell Carcinoma of Unknown Primary
| Record | Firm | Date |
|---|---|---|
| Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT04862650) | Marcelo Bonomi | 2021-11-30 |
| Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT03258554) | National Cancer Institute (NCI) | 2018-04-03 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625) | National Cancer Institute (NCI) | 2017-09-27 |
Track Squamous Cell Carcinoma of Unknown Primary automatically
Every clearance here is in the API, with alerts when new ones post.